Subdural haematoma represents an accumulation of blood between the dura, the outermost layer of the brain, and the next layer, also known as the arachnoid. Some of the common symptoms include convulsions, vomiting, speech and cognitive impairments, drowsiness and disorientation, vision disturbances, losing and regaining consciousness, numbness or weakness that may come and go, extreme fatigue, etc. It can be detected by a doctor who usually performs computed tomography (CT) or magnetic resonance imaging (MRI) scan. Additional tests are also performed, including a blood test to examine any complications with the clotting and eliminate any other possible reason for the apparent symptoms of patients.Ask an Analyst for Report Customization with TOC & List of figures: [FURL=https://bit.ly/3KGrhUI]https://bit.ly/3KGrhUI[/FURL]
Market Trend:
The rising number of head injuries and the growing utilization of alcohol are primarily driving the subdural haematoma market. Furthermore, the widespread adoption of aspirin and anti-inflammatory drugs, such as ibuprofen and anticoagulant medications, and the expanding geriatric population, who are more susceptible to brain shrinkage that occurs with aging, are also bolstering the market growth.
Apart from this, the escalating demand for contrast-enhanced MRI, as it can easily detect neo membranes, thick and extensive membranes, solid clots, etc., is acting as another significant growth-inducing factor. Moreover, the inflating popularity of burr-hole evacuation, which involves drilling one or more small holes in the skull and inserting a flexible rubber tube to drain the clot, is further positively influencing the global market. Besides this, key market players are investing in R&D activities to understand the merits and limitations of several surgical techniques, which is anticipated to fuel the subdural haematoma market over the forecasted period.
Request a Free Sample Report: [URL=https://www.imarcgroup.com/subdural-haematoma-market/requestsample]https://www.imarcgroup.com/subdural-haematoma-market/requestsample[/URL]
Key Questions Answered in this Report:
How has the subdural haematoma market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the subdural haematoma market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the subdural haematoma market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800